Mahesh Karande - Mar 9, 2022 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGA)

Role
President and CEO, Director
Signature
/s/ Barbara Chan as Attorney-in-Fact for Mahesh Karande
Stock symbol
OMGA
Transactions as of
Mar 9, 2022
Transactions value $
$0
Form type
4
Date filed
3/11/2022, 03:05 PM
Previous filing
Feb 3, 2022
Next filing
Oct 28, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Option (Right to Buy) Award $0 +340K $0.00 340K Mar 9, 2022 Common Stock 340K $10.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable with respect to 25% of the underlying shares on March 9, 2023 and in equal quarterly installments thereafter such that the option will become fully vested and exercisable on March 9, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.